Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007

To describe factors associated with multidrug-resistant (MDR), including extensively-drug-resistant (XDR), tuberculosis (TB) in the United States, we abstracted inpatient, laboratory, and public health clinic records of a sample of MDR TB patients reported to the Centers for Disease Control and Prev...

Full description

Bibliographic Details
Main Authors: Suzanne M. Marks, Jennifer Flood, Barbara Seaworth, Yael Hirsch-Moverman, Lori Armstrong, Sundari Mase, Katya Salcedo, Peter Oh, Edward A. Graviss, Paul W. Colson, Lisa Armitige, Manuel Revuelta, Kathryn Sheeran
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2014-05-01
Series:Emerging Infectious Diseases
Subjects:
Tuberculosis
drug resistance
cost
treatment practices
outcomes
multidrug-resistant tuberculosis
Online Access:https://wwwnc.cdc.gov/eid/article/20/5/13-1037_article

Internet

https://wwwnc.cdc.gov/eid/article/20/5/13-1037_article

Similar Items